Recombinant Vanderwaltozyma polyspora 3-ketoacyl-CoA reductase (Kpol_513p6)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized fulfillment.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires advance notice and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to collect the contents. Reconstitute the protein in sterile, deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a reference.
Shelf Life
Shelf life depends on various factors including storage conditions, buffer composition, temperature, and protein stability. Generally, liquid forms have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
Kpol_513p6; Very-long-chain 3-oxoacyl-CoA reductase; 3-ketoacyl-CoA reductase; 3-ketoreductase; KAR; Microsomal beta-keto-reductase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-347
Protein Length
full length protein
Species
Vanderwaltozyma polyspora (strain ATCC 22028 / DSM 70294) (Kluyveromyces polysporus)
Target Names
Kpol_513p6
Target Protein Sequence
MLDSFMTQLEIVGNRSKCVNMLLWSIFGFGVLKATTLILRIMACFVDLFVLPPVNYSKYG SKNGNYCVITGASDGIGKEFAFQMAKRGFNLILISRTLSKLETLQKEISTKYNVKVEVLA IDVAKDSEDNYSAIKELCGKFPITALINNVGQSHSIPVPFLETDEDEMRRIITINNTATL MITQIIAPMIIKTTKESSKKTRGLILTMGSFGGLIPTPLLATYSGSKAFLQSWSSSLAGE LKEHNVDVELIISYLVTSSMSKIRKTSMMIPNPKTFVASTLRNIGRRCGAQERYATITPY WSHALYQLAIVEAVGVYSHLVNYINYVFHKSIRIRALKKAARDAKKQ
Uniprot No.

Target Background

Function

Recombinant Vanderwaltozyma polyspora 3-ketoacyl-CoA reductase (Kpol_513p6) is a component of the microsomal membrane-bound fatty acid elongation system. It is involved in the production of 26-carbon very long-chain fatty acids (VLCFAs) from palmitate by catalyzing the reduction of the 3-ketoacyl-CoA intermediate in each elongation cycle. VLCFAs serve as precursors for ceramide and sphingolipids.

Database Links
Protein Families
Short-chain dehydrogenases/reductases (SDR) family
Subcellular Location
Endoplasmic reticulum membrane; Single-pass membrane protein.

Q&A

What is Vanderwaltozyma polyspora 3-ketoacyl-CoA reductase and what is its function?

Vanderwaltozyma polyspora 3-ketoacyl-CoA reductase (Kpol_513p6) is an enzyme involved in fatty acid elongation pathways. It catalyzes the second step in each cycle of fatty acid elongation, specifically the NADPH-dependent reduction of 3-ketoacyl-CoA to 3-hydroxyacyl-CoA. This enzyme is part of the very long chain fatty acid biosynthetic machinery and plays a crucial role in lipid metabolism. The enzyme belongs to the short-chain dehydrogenase/reductase (SDR) family and has the EC classification 1.1.1.-. It is also known by several synonyms including 3-ketoreductase, KAR, and microsomal beta-keto-reductase .

The full-length protein consists of 347 amino acids and contains conserved motifs typical of the SDR family. In the fatty acid elongation cycle, it works sequentially with three other enzymes: 3-ketoacyl-CoA synthase (KCS), 3-hydroxyacyl-CoA dehydratase (HCD), and enoyl-CoA reductase (ECR). Together, these enzymes extend fatty acid chains by two carbon atoms in each cycle .

What expression systems are suitable for producing recombinant Kpol_513p6?

Recombinant Kpol_513p6 can be successfully expressed in multiple heterologous systems. The most common expression host is Escherichia coli, which offers high yield and relatively straightforward purification procedures. The gene encoding Kpol_513p6 (residues 1-347) is typically cloned into an expression vector (such as pET-28b) that allows for the addition of an N-terminal histidine tag. Alternative expression systems include:

  • Yeast expression systems

  • Baculovirus-insect cell systems

  • Mammalian cell culture systems

  • Cell-free expression systems

Each system has its advantages and limitations depending on research requirements. E. coli systems are preferred for high yield and cost-effectiveness, while eukaryotic systems may provide better post-translational modifications. The choice of expression system should be based on the specific requirements of the research project, such as protein folding needs, post-translational modifications, and downstream applications .

How should recombinant Kpol_513p6 be stored to maintain optimal activity?

To maintain optimal activity of recombinant Kpol_513p6, the following storage conditions are recommended:

Storage ConditionRecommendation
Long-term storage-20°C to -80°C
Working aliquots4°C for up to one week
Buffer compositionTris/PBS-based buffer, pH 8.0, with 6% Trehalose
Alternative bufferTris-based buffer with 50% glycerol
Important precautionAvoid repeated freeze-thaw cycles

For reconstitution of lyophilized protein, it is recommended to briefly centrifuge the vial before opening and reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL. For long-term storage, addition of 5-50% glycerol (final concentration) is recommended before aliquoting. The standard recommended final concentration of glycerol is 50% .

What are the optimal conditions for assaying Kpol_513p6 enzymatic activity?

Determining the optimal conditions for assaying Kpol_513p6 activity requires careful consideration of multiple parameters. Based on related 3-ketoacyl-CoA reductases, a systematic approach to enzyme characterization should include:

  • Substrate specificity testing: Using various chain-length 3-ketoacyl-CoA substrates (C4-C26) to determine chain length preference.

  • Temperature optimization: Testing activity range from 20-55°C, with expected optimal activity likely between 30-40°C for yeast-derived enzymes.

  • pH optimization: Testing buffers ranging from pH 6.0-9.0, with common buffers including:

    • MES buffer (pH 6.0-6.5)

    • Phosphate buffer (pH 6.5-7.5)

    • Tris-HCl buffer (pH 7.5-9.0)

  • Cofactor requirements: NADPH is the likely preferred cofactor, but NADH should also be tested at concentrations of 0.1-1.0 mM.

  • Reaction monitoring: Activity can be monitored by:

    • Spectrophotometric assay following NADPH oxidation at 340 nm

    • HPLC analysis of substrate consumption and product formation

    • LC-MS/MS for detailed product characterization

For kinetic measurements, both continuous and discontinuous assays can be employed. Continuous assays monitoring NADPH consumption at 340 nm provide real-time data but may be less sensitive for slow reactions. Discontinuous assays involving product extraction and analysis at defined time points can provide more comprehensive data on reaction products .

How can I determine the kinetic parameters of recombinant Kpol_513p6?

Determining kinetic parameters of recombinant Kpol_513p6 requires careful experimental design and data analysis. A comprehensive approach should include:

  • Substrate saturation curves: Set up reactions with varying concentrations of 3-ketoacyl-CoA substrate (typically 0.001-1.0 mM) while keeping enzyme concentration constant. Multiple chain-length substrates should be tested to determine substrate preference.

  • Initial velocity measurements: Measure reaction rates during the linear phase (typically first 10-20% of substrate conversion) to determine initial velocities (v₀) at each substrate concentration.

  • Michaelis-Menten analysis: Plot initial velocity versus substrate concentration and fit to the Michaelis-Menten equation:
    v₀ = (Vₘₐₓ × [S]) / (Kₘ + [S])

  • Lineweaver-Burk transformation: For visual confirmation and alternative analysis, plot 1/v₀ versus 1/[S] to obtain a straight line with y-intercept = 1/Vₘₐₓ and slope = Kₘ/Vₘₐₓ.

  • Calculation of catalytic efficiency: Determine kcat (turnover number) by dividing Vₘₐₓ by enzyme concentration, then calculate catalytic efficiency as kcat/Kₘ.

The HT-MEK (High-Throughput Microfluidic Enzyme Kinetics) technique could be particularly valuable for comprehensive kinetic analysis of Kpol_513p6. This method enables thousands of enzyme experiments to be performed simultaneously, significantly accelerating the determination of kinetic parameters across multiple conditions and substrates .

What strategies can be employed for improving the yield and purity of recombinant Kpol_513p6?

Optimizing yield and purity of recombinant Kpol_513p6 requires attention to expression conditions and purification methods:

  • Expression optimization:

    • Test multiple E. coli strains (BL21(DE3), Rosetta, Arctic Express)

    • Optimize induction conditions:

      • IPTG concentration (0.1-1.0 mM)

      • Induction temperature (15-30°C)

      • Induction duration (4-24 hours)

    • Consider co-expression with chaperones if solubility is an issue

  • Cell lysis optimization:

    • Use a combination of enzymatic (lysozyme) and mechanical (sonication) methods

    • Include protease inhibitors to prevent degradation

    • Optimize buffer conditions (pH, salt concentration) to enhance protein stability

  • Advanced purification protocol:

    • Primary purification: Ni²⁺-NTA affinity chromatography

      • Use gradient elution with increasing imidazole (10-500 mM)

      • Collect fractions and analyze by SDS-PAGE

    • Secondary purification if needed:

      • Size exclusion chromatography

      • Ion exchange chromatography

  • Final polishing steps:

    • Dialysis against appropriate storage buffer

    • Concentration using centrifugal filters

    • Quality control by SDS-PAGE, enzyme activity, and mass spectrometry

A typical purification protocol based on successful approaches with similar enzymes involves loading the soluble portion of cell lysate onto a Ni²⁺-NTA affinity matrix, washing with equilibration buffer (typically 50 mM phosphate buffer, pH 7.5, containing 10 mM imidazole), and eluting the bound His-tagged protein with elution buffer (50 mM phosphate buffer, pH 7.5, containing 500 mM imidazole). Purified protein can then be dialyzed against an appropriate storage buffer .

How does Kpol_513p6 compare functionally to 3-ketoacyl-CoA reductases from other organisms?

Comparative analysis of Kpol_513p6 with homologous enzymes from other organisms provides insights into functional conservation and divergence:

ParameterYeast KCRsPlant KCRsBacterial Homologs
Kₘ (μM)10-1005-5020-200
kcat (s⁻¹)5-5010-1001-20
kcat/Kₘ (s⁻¹μM⁻¹)0.1-50.5-100.05-1
  • Functional complementation: Experiments in heterologous systems can reveal functional equivalence. For example, expression of Kpol_513p6 in E. coli or other systems lacking endogenous KCR activity can demonstrate whether it can functionally replace the native enzyme. Similar complementation experiments with the E. coli fabG gene (encoding 3-ketoacyl-ACP reductase) have demonstrated functional connections between fatty acid metabolism enzymes from different organisms .

What are the challenges in measuring the impact of metal ions and inhibitors on Kpol_513p6 activity?

Investigating the effects of metal ions and potential inhibitors on Kpol_513p6 activity presents several methodological challenges that require careful experimental design:

  • Metal ion effects assessment:

    • Systematic testing of divalent cations (Mg²⁺, Ca²⁺, Zn²⁺, Cu²⁺, Mn²⁺, Fe²⁺) at concentrations ranging from 0.1-10 mM

    • Control for background reactions (some metals can promote non-enzymatic reactions)

    • Consider chelation effects in buffers (EDTA, EGTA can sequester metals)

    • Potential for enhancement effects (some 3-ketoreductases show enhanced activity with specific ions, such as the 391% enhancement observed with Cu²⁺ for EstRag)

  • Inhibitor screening methodologies:

    • Test known inhibitors of related enzymes (SDR family inhibitors)

    • Determine IC₅₀ values through dose-response curves

    • Distinguish between competitive, non-competitive, and uncompetitive inhibition through Lineweaver-Burk analysis

    • Account for potential solubility issues with hydrophobic inhibitors

  • Detergent sensitivity analysis:

    • Test common detergents (SDS, Triton X-100, Tween-80) at 0.01-0.1% concentrations

    • Assess both immediate effects and stability after pre-incubation

    • Consider micelle formation and potential substrate sequestration

  • Data interpretation challenges:

    • Differentiating direct enzyme inhibition from interference with assay systems

    • Accounting for synergistic or antagonistic effects between metals and inhibitors

    • Correlating in vitro inhibition with potential physiological relevance

Methodologically, it is advisable to use multiple assay approaches to confirm inhibition results and to include appropriate controls for non-enzymatic reactions and assay interference. Additionally, thermal shift assays can provide complementary data on how metal ions or inhibitors affect protein stability, potentially offering insights into their mechanism of action .

How can Kpol_513p6 be utilized for metabolic engineering of fatty acid synthesis pathways?

Kpol_513p6 offers significant potential for metabolic engineering applications focused on modifying fatty acid synthesis pathways:

  • Co-expression strategies:

    • Pairing Kpol_513p6 with other enzymes from the fatty acid elongation pathway can redirect carbon flux

    • Co-expression with 3-ketoacyl-CoA synthases (KCS) with different chain-length specificities can produce targeted fatty acid profiles

    • Based on successful approaches with related enzymes, co-expression of Kpol_513p6 with polyhydroxyalkanoate (PHA) synthase genes could enable production of novel biopolymers

  • Pathway optimization considerations:

    • Balance expression levels of pathway enzymes to avoid metabolic bottlenecks

    • Consider cofactor availability (NADPH) and regeneration systems

    • Optimize cultivation conditions (temperature, carbon source, aeration)

  • Host strain selection factors:

    • E. coli strains with deletions in competing pathways (ΔfadE, ΔfadD)

    • Yeast systems with enhanced precursor supply

    • Systems with increased NADPH availability

  • Experimental design for pathway analysis:

    • Two-stage cultivation strategies (growth phase followed by production phase)

    • Testing of various carbon sources (glucose, fatty acids, acetate)

    • Analytical methods for product characterization (GC-MS, LC-MS)

As demonstrated with related enzymes such as the E. coli 3-ketoacyl-ACP reductase (fabG), co-expression of reductases with synthase genes can lead to the production of novel compounds. For example, co-expression of fabG with PHA synthase genes in E. coli HB101 resulted in accumulation of PHA copolymers (approximately 8% of dry cell weight) consisting of various 3-hydroxyalkanoate units when using dodecanoate as carbon source. Similar strategies could be employed with Kpol_513p6 to produce specialized fatty acid derivatives or biopolymers .

What are common pitfalls in enzymatic assays for Kpol_513p6 and how can they be addressed?

Enzymatic assays for 3-ketoacyl-CoA reductases like Kpol_513p6 present several potential pitfalls that can impact results reliability:

  • Substrate stability issues:

    • 3-ketoacyl-CoA substrates are prone to hydrolysis in aqueous solutions

    • Mitigation: Prepare fresh substrate solutions, consider including stabilizing agents, and monitor substrate integrity by HPLC

    • Time-course experiments should include substrate-only controls to account for non-enzymatic degradation

  • Cofactor-related challenges:

    • NADPH oxidation can occur non-enzymatically, especially in the presence of metal ions

    • Degradation of NADPH during storage can lead to inconsistent results

    • Solution: Include no-enzyme controls, prepare fresh NADPH solutions, and protect from light

  • Assay interference factors:

    • Buffer components may affect enzyme activity

    • Imidazole from purification can inhibit enzyme activity if not completely removed

    • Approach: Test multiple buffer systems and thoroughly dialyze protein preparations

  • Enzyme stability considerations:

    • Activity loss during storage or assay conditions

    • Protein aggregation affecting apparent activity

    • Recommendations: Monitor protein stability by dynamic light scattering, include thermal shift assays, and optimize buffer conditions

  • Data analysis complications:

    • Non-linear reaction kinetics due to substrate or product inhibition

    • Lag phases in enzyme activity due to conformational changes

    • Strategy: Limit analysis to initial velocity regions, employ appropriate non-linear regression models, and consider enzyme activation phenomena

To address these challenges, it is advisable to employ multiple complementary assay methods. For instance, coupling spectrophotometric NADPH consumption measurements with product formation analysis by chromatographic methods provides more robust data. Additionally, including appropriate controls and carefully optimizing assay conditions for each specific batch of enzyme can significantly improve reproducibility .

How can I design experiments to investigate the physiological role of Kpol_513p6 in Vanderwaltozyma polyspora?

Designing experiments to elucidate the physiological role of Kpol_513p6 in its native organism requires a multifaceted approach:

  • Gene deletion/silencing strategies:

    • CRISPR-Cas9 mediated gene knockout if transformation protocols exist for V. polyspora

    • RNA interference approaches if complete knockout is lethal

    • Conditional expression systems (tetracycline-regulated or similar)

    • Experimental readouts: Growth phenotypes, fatty acid profile alterations, membrane composition changes

  • Complementation experiments:

    • Reintroduction of wild-type Kpol_513p6 in knockout strains

    • Expression of site-directed mutants to identify critical residues

    • Heterologous complementation with KCR genes from other organisms

    • Analysis: Restoration of wild-type phenotypes, partial complementation effects

  • Metabolomic profiling approaches:

    • Comparative lipidomics between wild-type and mutant strains

    • Targeted analysis of very long-chain fatty acids and derivatives

    • Stable isotope labeling experiments to track metabolic flux

    • Techniques: GC-MS, LC-MS/MS, NMR for comprehensive metabolite identification

  • Subcellular localization studies:

    • Fluorescent protein tagging (ensuring tags don't disrupt function)

    • Immunolocalization with specific antibodies

    • Subcellular fractionation followed by activity assays or western blotting

    • Expected localization: Endoplasmic reticulum membrane, based on function in fatty acid elongation

  • Stress response characterization:

    • Response to temperature shifts, membrane stressors, osmotic challenges

    • Analysis of gene expression under various growth conditions

    • Correlation with changes in membrane lipid composition

    • Methods: qRT-PCR, RNA-seq, proteomics

These approaches should be integrated with in vitro biochemical characterization to establish clear connections between the enzyme's catalytic properties and its physiological function. The experimental design should also account for potential redundancy in 3-ketoacyl-CoA reductase activity, as many organisms possess multiple enzymes with overlapping functions .

What high-throughput methods can accelerate the characterization of Kpol_513p6 variants?

High-throughput methods offer powerful approaches to characterize multiple Kpol_513p6 variants simultaneously, enabling more comprehensive structure-function analyses:

  • High-Throughput Microfluidic Enzyme Kinetics (HT-MEK):

    • This technique enables thousands of enzyme experiments to be performed simultaneously

    • Microfluidic chips allow for precise control of reaction conditions

    • Automated analysis of reaction progress through integrated detection systems

    • Applications: Rapid screening of substrate specificity, inhibitor effects, and reaction conditions

    • Implementation requires specialized equipment but dramatically accelerates data collection

  • Deep mutational scanning approaches:

    • Creation of comprehensive mutant libraries covering single or multiple positions

    • Coupling of enzymatic activity to a selectable or screenable phenotype

    • Next-generation sequencing to quantify enrichment/depletion of variants

    • Analysis: Sequence-function relationships, identification of critical residues

    • Advantages: Thousands to millions of variants can be assessed simultaneously

  • Automated protein purification and characterization platforms:

    • Parallel expression and purification of dozens to hundreds of variants

    • Integration with robotic liquid handling for automated assay setup

    • Standardized analytical methods for consistent comparisons

    • Data management systems for tracking large datasets

    • Benefits: Reduced variability between experimental batches, improved reproducibility

  • Computational prediction integrated with experimental validation:

    • In silico modeling of mutations and their effects on structure and function

    • Molecular dynamics simulations to predict conformational changes

    • Machine learning approaches to prioritize variants for experimental testing

    • Iterative design-build-test cycles to refine understanding

  • Microscale thermophoresis and thermal shift assays:

    • Rapid assessment of protein stability and ligand binding

    • Miniaturized reaction formats requiring minimal protein amounts

    • Parallel analysis of multiple conditions in 96 or 384-well formats

    • Applications: Screening stability conditions, cofactor preferences, substrate binding

Implementing these high-throughput approaches requires careful experimental design and appropriate controls but can dramatically accelerate the characterization process and provide more comprehensive datasets than traditional methods .

How might structural biology approaches enhance our understanding of Kpol_513p6 function?

Structural biology approaches offer powerful insights into Kpol_513p6 function by revealing atomic-level details of enzyme-substrate interactions and catalytic mechanisms:

  • X-ray crystallography strategies:

    • Crystallization trials with various constructs (full-length, truncated, fusion proteins)

    • Co-crystallization with substrates, products, or inhibitors

    • Analysis of conformational changes upon ligand binding

    • Resolution goals: 1.5-2.5 Å for detailed catalytic site visualization

    • Challenges: Obtaining diffraction-quality crystals, capturing catalytically relevant states

  • Cryo-electron microscopy applications:

    • Single-particle analysis for structural determination

    • Visualization of conformational ensembles

    • Potential for studying membrane-associated states

    • Advantages: No crystallization required, observation of multiple conformational states

    • Limitations: Size constraints may necessitate complex formation or antibody labeling

  • NMR spectroscopy approaches:

    • Solution structure determination

    • Dynamics studies to identify flexible regions

    • Ligand binding experiments using chemical shift perturbation

    • Isotope labeling strategies (¹⁵N, ¹³C, ²H) for optimal signal quality

    • Applications: Characterizing protein-ligand interactions in solution, conformational changes

  • Integrative structural biology:

    • Combining multiple techniques (crystallography, cryo-EM, NMR, SAXS)

    • Computational modeling to fill experimental gaps

    • Molecular dynamics simulations to explore conformational space

    • Benefits: More complete structural understanding, dynamic information

  • Structure-guided enzyme engineering:

    • Identification of hotspots for mutagenesis

    • Rational design of variants with altered specificity

    • Computational prediction of mutations to enhance stability or activity

    • Correlation of structural features with kinetic parameters

Structural studies would be particularly valuable for understanding:

  • The binding mode of different chain-length substrates

  • Conformational changes during the catalytic cycle

  • The basis for NADPH vs. NADH preference

  • Potential oligomerization states and their functional significance

These approaches would complement biochemical and kinetic analyses to provide a comprehensive understanding of Kpol_513p6 structure-function relationships .

What are the most significant knowledge gaps in our understanding of Kpol_513p6?

Despite the available information on Recombinant Vanderwaltozyma polyspora 3-ketoacyl-CoA reductase (Kpol_513p6), several significant knowledge gaps remain that represent important opportunities for future research:

  • Detailed substrate specificity profile: While the general function of Kpol_513p6 as a 3-ketoacyl-CoA reductase is established, comprehensive characterization of its chain-length preferences and kinetic parameters across different substrates is lacking. Understanding these preferences would provide insights into its specific role in fatty acid elongation.

  • Structural determinants of function: No high-resolution structure of Kpol_513p6 has been published. Structural information would significantly enhance our understanding of its catalytic mechanism, substrate binding mode, and potential for enzyme engineering.

  • Physiological role in Vanderwaltozyma polyspora: The specific biological functions of Kpol_513p6 in its native organism remain incompletely understood. Questions regarding its role in stress responses, membrane homeostasis, and potential involvement in specialized lipid synthesis remain unanswered.

  • Regulatory mechanisms: How the expression and activity of Kpol_513p6 are regulated in response to changing environmental conditions or metabolic demands is not well characterized. Understanding these regulatory mechanisms would provide insights into the integration of fatty acid elongation with other metabolic pathways.

  • Comparative analysis with homologs: Systematic comparison of Kpol_513p6 with homologous enzymes from other organisms would help identify conserved features and unique characteristics that might be relevant to its specific function or evolutionary adaptation.

Addressing these knowledge gaps will require integrated approaches combining biochemical characterization, structural biology, systems biology, and physiological studies. The development and application of high-throughput methods, as discussed earlier, would significantly accelerate progress in filling these gaps .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.